Kezar Life Sciences

We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be applied across a vast array of indications to create victories for patients most in need.

Evommune

Chronic inflammatory diseases are the most significant cause of death in the world, and those who live with them have a reduced quality of life. Many immunology-focused medications give patients a temporary fix to a longer-term problem—addressing symptom control rather than the root cause of disease. Evommune is different. We strive to develop accessible innovations that are meant to address symptoms as well as help avoid disease progression and medical complications in the future.

Genomelink

Genomelink is a DNA App Store where people upload and store DNA data to access more insights, products, and health research. We are on missions to; - Build a world #1 consumer application platform - Help advancement of genomics and health science - Bring back DNA data ownership to your hand

genomed

Genomed is committed to developing and adapting leading edge technology to application solutions for molecular diagnostic laboratories. Over 20 years’ experience in the fields of Clinical Genetics and DNA based Forensics testing has resulted in an extensive company knowledge base, putting Genomed at the forefront of these technologies. The company has two divisions: • The development, manufacture and distribution of molecular diagnostic tests • Establishing complete Turn-Key Molecular Laboratories

Sri Lanka Institute of Biotechnology (SLIBTEC)

With the aim of stepping into the global market, that would bring revenue to Sri Lanka along with opportunities to harness the maximum from our highly skilled pool of human resources graduated from state and private universities and most importantly to establish a research and development landscape that could lead to breakthrough discoveries and innovations, Sri Lanka Institute of Biotechnology (SLIBTEC) was established as a fully government owned multidisciplinary research and development entity, incorporated under the Ministry of Education. With the prime objective of establishing a high-end biotech product development ecosystem together with increased exports, SLIBTEC is focusing to invest on diverse areas in order to provide biotech related solutions to contemporary and future nationally and globally important aspects. SLIBTEC comprises of two components, SLIBTEC Research, a state-of-the-art multidisciplinary research facility; and SLIBTEC Park, to facilitate the manufacture of high-end biotech products within a one-stop-shop for regulatory support. SLIBTEC will also expand its capacity as a Regional Research Centre for the International Centre for Genetic Engineering and Biotechnology (ICGEB) having unique facilities within the institute. Combining innovation, development, and production ends together and continued adoption of cutting-edge technologies will enable SLIBTEC to build a novel innovative eco-system in Sri Lanka while uplifting all the relevant sectors with essential facilities for biotech-based manufacturing and start-up operations.